Cross Country Healthcare (NASDAQ:CCRN) had its target price cut by investment analysts at SunTrust Banks from $12.00 to $9.00 in a report issued on Thursday, BenzingaRatingsTable reports. The firm presently has a “hold” rating on the business services provider’s stock. SunTrust Banks’ price objective would suggest a potential upside of 20.32% from the company’s previous close.

A number of other equities research analysts have also recently commented on the stock. Zacks Investment Research raised shares of Cross Country Healthcare from a “hold” rating to a “buy” rating and set a $8.25 price objective on the stock in a research note on Tuesday. Barrington Research reaffirmed an “outperform” rating on shares of Cross Country Healthcare in a research note on Tuesday, March 10th. Finally, BidaskClub raised shares of Cross Country Healthcare from a “sell” rating to a “hold” rating in a research note on Wednesday, March 18th. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $9.08.

Shares of NASDAQ:CCRN traded down $0.68 during trading on Thursday, reaching $7.48. The stock had a trading volume of 6,975 shares, compared to its average volume of 340,288. Cross Country Healthcare has a one year low of $6.43 and a one year high of $13.42. The company has a market capitalization of $324.36 million, a P/E ratio of -4.60, a PEG ratio of 4.05 and a beta of 1.03. The company has a current ratio of 2.15, a quick ratio of 2.15 and a debt-to-equity ratio of 0.55. The firm’s 50-day simple moving average is $9.20 and its 200 day simple moving average is $10.54.

Cross Country Healthcare (NASDAQ:CCRN) last announced its quarterly earnings data on Wednesday, March 4th. The business services provider reported $0.07 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.06 by $0.01. Cross Country Healthcare had a negative net margin of 7.02% and a positive return on equity of 3.02%. The firm had revenue of $215.10 million during the quarter, compared to analyst estimates of $208.08 million. Cross Country Healthcare’s revenue was up 7.1% compared to the same quarter last year. Equities research analysts forecast that Cross Country Healthcare will post 0.19 earnings per share for the current fiscal year.

In related news, Director Thomas C. Dircks purchased 4,293 shares of the company’s stock in a transaction that occurred on Tuesday, March 10th. The shares were purchased at an average price of $7.52 per share, with a total value of $32,283.36. Following the purchase, the director now owns 154,360 shares of the company’s stock, valued at $1,160,787.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Kevin Cronin Clark purchased 22,601 shares of the stock in a transaction dated Tuesday, March 10th. The shares were purchased at an average cost of $7.66 per share, for a total transaction of $173,123.66. Following the transaction, the chief executive officer now owns 272,575 shares in the company, valued at approximately $2,087,924.50. The disclosure for this purchase can be found here. In the last three months, insiders bought 27,894 shares of company stock worth $212,317. 3.80% of the stock is currently owned by company insiders.

Hedge funds have recently made changes to their positions in the business. Renaissance Technologies LLC raised its position in Cross Country Healthcare by 97.8% in the 4th quarter. Renaissance Technologies LLC now owns 458,930 shares of the business services provider’s stock worth $5,333,000 after purchasing an additional 226,930 shares during the period. Acadian Asset Management LLC increased its stake in Cross Country Healthcare by 141.8% in the 4th quarter. Acadian Asset Management LLC now owns 373,166 shares of the business services provider’s stock worth $4,334,000 after buying an additional 218,821 shares during the period. Millennium Management LLC purchased a new position in Cross Country Healthcare in the 3rd quarter worth about $1,673,000. Goldman Sachs Group Inc. boosted its holdings in shares of Cross Country Healthcare by 72.8% in the 4th quarter. Goldman Sachs Group Inc. now owns 187,112 shares of the business services provider’s stock valued at $2,174,000 after buying an additional 78,838 shares in the last quarter. Finally, Oxford Asset Management LLP increased its stake in Cross Country Healthcare by 87.1% during the fourth quarter. Oxford Asset Management LLP now owns 164,531 shares of the business services provider’s stock worth $1,912,000 after purchasing an additional 76,595 shares during the period. Institutional investors own 95.12% of the company’s stock.

Cross Country Healthcare Company Profile

Cross Country Healthcare, Inc provides healthcare staffing, recruiting, and workforce solutions in the United States. The company operates in three segments: Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, branch-based local nurses, and allied staffing; short-term staffing of registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and travel allied professionals on long-term contract assignments.

Read More: How Do I Invest in Dividend Stocks

Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.